Medical News

Combination of ENCO+BINI+CETUX Shows Improvement in OS and ORR in Patients with BRAF V600E-mutant mCRC

The BEACON CRC Study was a multicenter, randomized, open-label, 3-arm, phase 3 study to evaluate encorafenib (ENCO) + cetuximab (CETUX) with/without...

16 Jul, 2019

 
Email this page
Combination of Enzalutamide and Cisplatin Effective in Urothelial Carcinoma of Bladder

A recent study detected androgen receptor (AR) expression in a significant percentage of male patients with muscle invasive bladder cancer (MIBC)....

12 Jul, 2019

 
Email this page
Predicting Chemotherapy Benefit with Combined Clinical and Genomic Risk in Breast Cancer Patients

Trial Assigning Individualized Options for Treatment (TAILORx), a prospective trial showed that endocrine therapy was non-inferior to chemoendocrine...

27 Jun, 2019

 
Email this page
Survival Outcomes with Partial Nephrectomy versus Radical Nephrectomy in RCC

A recent meta-analysis showed that the overall survival (OS) and recurrence-free survival (RFS) outcomes with partial nephrectomy (PN) for 4 cm to 7...

18 Jun, 2019

 
Email this page

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

ALTERNATIVE Trial: LAP+ TRAS+ AI as Sparing Alternative Regimen for Metastatic Breast Cancer

ALTERNATIVE Trial is the first large randomized trial that evaluated dual HER2 blockade plus an aromatase inhibitor for HER2-positive/HR-positive...

LANDSCAPE TRIAL: Lapatinib in Combination with Capecitabine Active As First-line Treatment of Brain Metastases from HER2-positive Breast Cancer

This is the first prospective phase 2 trial assessing a combination of chemotherapy and targeted therapy in patients with previously untreated brain...

Risk Predictors of Brain Metastases Development in Patients with HER2- Positive Breast Cancer

This study presents the risk factors for the development of the brain metastases for early and advanced (metastatic) HER2+breast cancer, local...

GeparQuinto Trial: Lapatinib versus Trastuzumab in Combination with Chemotherapy for Treatment of HER2-positive Primary Breast Cancer

GeparQuinto trial is phase 3 study comparing lapatinib versus trastuzumab in combination with chemotherapy for treatment of HER2-positive primary...

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

All You Wanted to Know about Oral Mucositis/Stomatitis

Problems, causes, common symptoms, prevention and treatment of oral mucositis/stomatitis are given in question & answer format.

Infographics

Explore >>

Currently there is no content under this category.

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
43% (3 votes)
Tegafur uracil
0% (0 votes)
5-FU
57% (4 votes)
Total votes: 7